Leading Developer of Transformative Hip Arthroplasty Solutions

With an IDE Study Underway

What We Provide

Innovative Technology

We create products using the latest innovative technology, with support from Hip Resurfacing Arthroplasty (HRA) pioneers.

Solution Provider

Our aim is to establish JointMedica as the go-to solution provider for the arthroplasty markets.

Patient Led

We respond to the direct needs of the patients, providing unique devices to support the increasing demand in longer implant survivorship.

JointMedica will be the leading developer of transformative hip arthroplasty solutions, with dedication to the highest quality manufacturing and industry leading clinical performance.

Polymotion

Hip Resurfacing

*Pending Regulatory Approval

BLOGS

Latest News from JointMedica

1 July 2025

JointMedica announces launch of IDE Study for Polymotion Hip Resurfacing System

JointMedica, a global leader in orthopedic innovation, announces the commencement of an Investigational Device Exemption (IDE) study for its Polymotion® Hip Resurfacing (PHR®) device.

Start Now

23 June 2025

Polymotion IDE Study Reaches 30% Enrolment Milestone

We are pleased to announce that the Polymotion® Hip Resurfacing (PHR®) IDE study has now reached 30% of its target enrolment.

Start Now

19 May 2025

Hip resurfacing arthroplasty reduces dislocation and infection rates...

In a recent network meta-analysis “Hip resurfacing arthroplasty reduces dislocation and infection rates without differences in clinical outcomes compared to short and standard stems

Start Now

8 May 2025

Hip Resurfacing Not Just for the Young

In a systematic review published earlier this year, Marwin et al. (2025) stated “There is no significant difference in postoperative outcomes between younger and older patients undergoing HRA.

Start Now